Serum inflammatory mediators correlate with disease activity in electrical status epilepticus in sleep (ESES) syndrome

Bart van den Munckhof, Evelien E de Vries, Kees P J Braun, H Myrthe Boss, Michèl A Willemsen, Annet van Royen, Wilco de Jager, Floor E Jansen

Research output: Contribution to journalArticleAcademicpeer-review

Abstract

We aimed to study serum cytokine levels in 11 electrical status epilepticus in sleep (ESES) patients and 20 healthy control children. Patients showed significantly higher levels of interleukin (IL)-1α, IL-6, IL-10, chemokine (C-C motif) ligand (CCL)2 and chemokine (C-X-C motif) ligand (CXCL)8/IL-8 than controls, while macrophage migration inhibitory factor (MIF) and CCL3 were significantly lower. Follow-up analyses in five patients revealed a significant decrease of IL-6 levels after immunomodulating treatment. IL-6 changes were accompanied by clear improvement of electroencephalography (EEG) patterns and neuropsychological evaluation. We hypothesize that IL-6 correlates with disease activity and immunomodulating treatment efficacy.

Original languageEnglish
Pages (from-to) e45–e50
JournalEpilepsia
Volume57
Issue number2
DOIs
Publication statusPublished - Feb 2016

Keywords

  • Cytokines
  • Electrical status epilepticus during sleep
  • ESES
  • Continuous spikes and waves during sleep
  • CSWS
  • Landau-Kleffner syndrome

Fingerprint

Dive into the research topics of 'Serum inflammatory mediators correlate with disease activity in electrical status epilepticus in sleep (ESES) syndrome'. Together they form a unique fingerprint.

Cite this